Table 1.
Parameter | Reperfused | Non-Reperfused | P * | ||||
---|---|---|---|---|---|---|---|
MRI | TTC | P | MRI | TTC | P | ||
LVM (g) | 69.4 ± 21.3 | 74.2 ± 27.9 | 0.094 | 80.2 ± 22.3 | 76.6 ± 21.7 | 0.109 | 0.077 |
MI (ml) | 17.1 ± 3.4 | 18.8 ± 4.4 | 0.216 | 19.4 ± 8.1 | 18.1 ± 7.8 | 0.484 | 0.090 |
MIF (%LVM) | 27.3 ± 12.2 | 30.5 ± 15.5 | 0.202 | 24.3 ± 7.7 | 24.6 ± 10.1 | 0.625 | 0.158 |
NF (ml) | 7.7 ± 2.4 | 8.1 ± 1.9 | 0.211 | ||||
NFF (%LVM) | 12.6 ± 7.8 | 10.1 ± 3.3 | 0.114 | ||||
NFF (%MI) | 44.6 ± 7.6 | 41.5 ± 9.9 | 0.278 |
MRI magnetic resonance imaging, TTC triphenyltetrazolium chloride staining, LVM left ventricular mass, MI myocardial infarct, MIF MI fraction, NF no-flow region, NFF no-flow fraction. * P value for comparison of measurements in the reperfused and non-reperfused groups based on MRI